نتایج جستجو برای: eluting stents • treatment failure • myocardial infarction

تعداد نتایج: 1845761  

Journal: :the journal of tehran university heart center 0
abbasali rafighdust imam reza hospital, mashhad university of medical sciences, mashhad, iran. ali eshraghi imam reza hospital, mashhad university of medical sciences, mashhad, iran.

the invention of the drug-eluting stent (des) has brought about revolutionary changes in the field of interventional cardiology. in the des era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged. one of the emerging paradigms in the des era is stent fracture. there are reports about stent fracture leading to in-stent restenosis or stent thrombosis. most of th...

Journal: :Jacc-cardiovascular Interventions 2021

The aim of this study was to investigate the safety and efficacy biodegradable-polymer sirolimus-eluting stents (BP-SES) compared with durable-polymer everolimus-eluting (DP-EES) in patients ST-segment elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention (PCI) is an effective treatment for STEMI, long-term outcomes are determined by profile newest generation drug-...

Journal: :Revista espanola de cardiologia 2013
Salvatore Cassese Steffen Desch Adnan Kastrati Robert A Byrne Lamin King Tomohisa Tada Bernward Lauer Albert Schömig Holger Thiele Jürgen Pache

INTRODUCTION AND OBJECTIVES The angiographic and clinical efficacy of polymer-free sirolimus-eluting stents vs polymer-based paclitaxel-eluting stents remain a matter of debate. We sought to investigate angiographic and clinical measures of efficacy of polymer-free sirolimus-eluting stents vs polymer-based paclitaxel-eluting stents. METHODS Patient data from the randomized intracoronary stent...

Journal: :Lancet 2014
Thomas Pilgrim Dik Heg Marco Roffi David Tüller Olivier Muller André Vuilliomenet Stéphane Cook Daniel Weilenmann Christoph Kaiser Peiman Jamshidi Therese Fahrni Aris Moschovitis Stéphane Noble Franz R Eberli Peter Wenaweser Peter Jüni Stephan Windecker

BACKGROUND Refinements in stent design affecting strut thickness, surface polymer, and drug release have improved clinical outcomes of drug-eluting stents. We aimed to compare the safety and efficacy of a novel, ultrathin strut cobalt-chromium stent releasing sirolimus from a biodegradable polymer with a thin strut durable polymer everolimus-eluting stent. METHODS We did a randomised, single-...

Journal: :The New England journal of medicine 2007
Adnan Kastrati Julinda Mehilli Jürgen Pache Christoph Kaiser Marco Valgimigli Henning Kelbaek Maurizio Menichelli Manel Sabaté Maarten J Suttorp Dietrich Baumgart Melchior Seyfarth Matthias E Pfisterer Albert Schömig

BACKGROUND The long-term effects of treatment with sirolimus-eluting stents, as compared with bare-metal stents, have not been established. METHODS We performed an analysis of individual data on 4958 patients enrolled in 14 randomized trials comparing sirolimus-eluting stents with bare-metal stents (mean follow-up interval, 12.1 to 58.9 months). The primary end point was death from any cause....

توان, حامد, رای, علیرضا, سلیمی, ابراهیم, نوروزی, سیروس,

Background: Cardiovascular diseases alone have become the leading cause of death worldwide. One of the treatment methods cardiovascular disease is angioplasty. This study aimed to investigate the clinical results after coronary artery angioplasty, based on the incidence of major cardiovascular events with emphasis on stent types. Methods: In this retrospective cross-sectional study, the preval...

Journal: :Circulation 2009
Yan Li Zhe Zheng Bo Xu Shiju Zhang Wei Li Runlin Gao Shengshou Hu

BACKGROUND Numerous studies have compared the outcomes of coronary artery bypass grafting (CABG) surgery and coronary stenting for the treatment of multivessel coronary disease. In 2003, drug-eluting stents were introduced with the hope of reducing restenosis. However, limited information exists on the comparison of drug-eluting stents and CABG surgery. The long-term outcome of drug-eluting ste...

Journal: :Circulation 2011
Gregg W Stone Elvin Kedhi Dean J Kereiakes Helen Parise Martin Fahy Patrick W Serruys Pieter C Smits

BACKGROUND Some (but not all) prior trials have reported differential outcomes after percutaneous coronary intervention with paclitaxel-eluting stents versus stents eluting rapamycin analogs according to the presence of diabetes mellitus. These studies lacked sufficient power to examine individual safety and efficacy end points. METHODS AND RESULTS To determine whether an interaction exists b...

Journal: :The New England journal of medicine 2010
Christoph Kaiser Soeren Galatius Paul Erne Franz Eberli Hannes Alber Hans Rickli Giovanni Pedrazzini Burkhard Hornig Osmund Bertel Piero Bonetti Stefano De Servi Hans-Peter Brunner-La Rocca Ingrid Ricard Matthias Pfisterer

BACKGROUND Recent data have suggested that patients with coronary disease in large arteries are at increased risk for late cardiac events after percutaneous intervention with first-generation drug-eluting stents, as compared with bare-metal stents. We sought to confirm this observation and to assess whether this increase in risk was also seen with second-generation drug-eluting stents. METHOD...

Journal: :Revista espanola de cardiologia 2014
Petri O Tuomainen Jussi Sia Wail Nammas Matti Niemelä Juhani K E Airaksinen Fausto Biancari Pasi P Karjalainen

INTRODUCTION AND OBJECTIVES We performed a pooled analysis based on patient-level data from the TITAX-AMI and BASE-ACS trials to evaluate the outcome of titanium-nitride-oxide-coated bioactive stents vs drug-eluting stents in patients with ST-segment elevation myocardial infarction at 2-year follow-up. METHODS The TITAX-AMI trial compared bioactive stents with paclitaxel-eluting stents in 425...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید